In vitro evaluation of apheresis platelet and plasma products collected and stored in non‐ DEHP disposable sets
Vox Sanguinis · 2026
DOI: 10.1111/vox.70318 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Vox Sanguinis, 2026. Verfasst von Susanne Marschner und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vitalant Research Institute, Denver, Colorado, USA. Hauptthemen laut MEDLINE: Plasma, Blood Preservation, Blood Platelets, Plateletpheresis. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Terumo BCT.
Abstract (Originalsprache)
Background and Objectives Di(2‐ethylhexyl) phthalate (DEHP) has been classified as a reproductive toxicant and endocrine disruptor and will be banned in the European Union (EU) in blood bags starting in July 2030. Alternative plasticizers are being developed, and this study is the first to report on platelets and plasma collected using investigational non‐DEHP apheresis sets. Materials and Methods Randomized, crossover collections of platelet and plasma products from identical participants in DEHP and non‐DEHP sets were performed. Plasma was studied as fresh frozen plasma (FFP) and stored in non‐DEHP bags. Additional plasma‐only collections evaluated plasma frozen within 24 h after phlebotomy and held at room temperature for up to 24 h (PF24RT24). Platelet and plasma quality parameters were evaluated against the US Food and Drug Administration (FDA) and the European Directorate for the Quality of Medicines & HealthCare (EDQM) criteria.
Results
Platelet products ( n = 33 pairs) met all FDA/EDQM standards, and in vitro parameters were within the predetermined 20% equivalency margin. FFP products ( n = 33 pairs) met the EDQM criteria. Factor VIII retention after ≥30 days of frozen storage was on average 88.4%. All parameters for PF24RT24 products ( n = 31 pairs) met the 20% equivalency margin after >31 days of frozen storage. No serious adverse events in study participants were reported.
Conclusion
Non‐DEHP apheresis disposable sets collect transfusion‐quality platelet and plasma components, supporting the phasing out of DEHP and reducing exposure to this plasticizer, without compromising participant safety and quality of the collected products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vitalant Research Institute, Denver, Colorado, USA.
- Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA.
- American Red Cross, Rockville, Maryland, USA.
- American Red Cross, Norfolk, Virginia, USA.
- Terumo Blood and Cell Technologies, Lakewood, Colorado, USA.
- Lifetime Scientific, Inc., Dundas, Ontario, Canada.
ORCID-Profile: Susanne Marschner, Caroline R Alquist, Bethany Brown
Förderung
- Terumo BCT
Zitieren
APA
Marschner, S., Alquist, C. R., Brown, B., Rice, J. D., Gloor, C., Gorman, J., Sedjo, R. L., Mason, E., Rhodes, J. P., López, P., Rugg, N., Cook, R., & Mack, S. E. (2026). In vitro evaluation of apheresis platelet and plasma products collected and stored in non‐ DEHP disposable sets. Vox Sanguinis. https://doi.org/10.1111/vox.70318
Vancouver
Marschner S, Alquist CR, Brown B, Rice JD, Gloor C, Gorman J, et al. In vitro evaluation of apheresis platelet and plasma products collected and stored in non‐ DEHP disposable sets. Vox Sanguinis. 2026. doi:10.1111/vox.70318
BibTeX
@article{Marschner2026,
author = {Marschner, Susanne and Alquist, Caroline R and Brown, Bethany and Rice, Joseph D and Gloor, Christina and Gorman, Jeremiah and Sedjo, Rebecca L and Mason, Emily and Rhodes, Jack P and López, Phillip and Rugg, Neeta and Cook, Richard and Mack, Samantha E},
title = {In vitro evaluation of apheresis platelet and plasma products collected and stored in non‐ DEHP disposable sets},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70318}
}
EUVIMED